WorksheetsVildagliptin Quiz
Total questions: 20
Worksheet time: 10mins
Vildagliptin was first synthesized by researchers at which company?
USV
Novartis
Torrent
Alkem
USV launched Jalra in partnership with which multinational company?
Sanofi
Novartis
GSK
Cipla
Jalra OD contains which form of Vildagliptin?
Immediate release 100 mg
Sustained release 100 mg
Controlled release 50 mg
Delayed release 100 mg
Recommended daily dose of Vildagliptin is:
50 mg OD
50 mg BID
100 mg OD
150 mg OD
As per VA, Jalra OD should be added on to which therapy?
Metformin alone
SU or SU + Metformin
Insulin only
DPP4 inhibitor
Jalra M is preferred for:
Drug naïve T2DM patients
Uncontrolled on Metformin
Patients with CV risk
Pediatric diabetes
Jalra DP is indicated for T2DM patients with:
High HbA1c
CV risk
Renal impairment
Weight gain
The result of DPP-4 inhibition by Vildagliptin is:
Reduced insulin secretion
Enhanced incretin activity
Increased glucagon
Reduced GLP-1
Vildagliptin provides how many extra hours in range compared to Sitagliptin?
1 hour
2 hours
3 hours
4 hours
The VERIFY trial demonstrated:
Higher hypoglycemia with Vilda+Met
Reduced second treatment failure
Weight gain
No difference in HbA1c
Early combination of Vildagliptin + Metformin improved which function?
Renal
Liver
Beta cell
Alpha cell
Which of the following is NOT a benefit of Vildagliptin?
Weight neutrality
Reduction in glycemic variability
Risk of edema
Improvement in insulin sensitivity
Vildagliptin is safe for use in:
Pediatric
Liver impaired
Mild-to-severe renal impairment
Pregnant women
Which patient group requires no dose adjustment with Vildagliptin?
Geriatric
Hepatic
Pediatric
Pregnant
Vildagliptin shows how much HbA1c reduction?
0.48%
0.71%
1.1%
0.9%
Vildagliptin has what kind of cardiovascular profile?
Harmful
Neutral/Safe
High-risk
Unknown
For eGFR <30 ml/min, the dose of Vildagliptin is:
25 mg
50 mg
75 mg
Not recommended
How does Vildagliptin differ from Sitagliptin in excretion profile?
Completely hepatic
Predominantly renal
Intermediate renal excretion
Non-renal
Jalra OD provides bioequivalence to:
Vildagliptin 50 mg OD
Vildagliptin 50 mg BID
Vildagliptin 100 mg BID
Vildagliptin 50 mg TID
Jalra OD is suitable for:
Pediatric diabetes
Patients on insulin or dual/triple therapy
GDM patients
Newly diagnosed only
